Author: , The Fayetteville Observer

AI research biotech Earendil Labs has penned a $885 million deal to use WuXi XDC’s linker-payload technology to create next-gen antibody-drug conjugates (ADCs). | AI research biotech Earendil Labs has penned a $885 million deal to use WuXi XDC’s linker-payload technology to create next-gen antibody-drug conjugates (ADCs).Read More

Read More